Medication info
Primonoc Tablet 80 mg (Telmisartan)

Primonoc Tablet 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Dongguk Pharmaceutical Co., Ltd.
Appearance
White or nearly white, biconvex, round tablets
Packaging
10 tablets/blister X 3
Approval status
Active

MFDS item code 201907891 · Approved 2019.11.13 · Insurance code 653405090

Summary

Main use
Treatment of essential hypertension; reduction of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Dongguk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction of cardiovascular disease risk

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinically evident high-risk diabetes with end-organ damage
  • myocardial infarction
View approved original text

This medication is used to treat essential hypertension. It also helps reduce the risk of myocardial infarction, stroke, and death from cardiovascular disease in high-risk patients aged 55 and older, particularly when ACE inhibitors cannot be used. It is effective for those with cardiovascular disease or end-organ damage due to diabetes, contributing to the protection of cardiovascular health and reduction of risk.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication may cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be administered to patients with hypersensitivity to this drug, pregnant or breastfeeding women, severe liver impairment patients, hereditary angioedema patients, and certain renal impairment patients. Caution should be exercised for elderly patients, hyperkalemia patients, mild to moderate liver impairment patients, patients with valvular heart disease, and patients with ischemic heart disease. Various adverse reactions may occur during treatment with this medication; hence, special attention should be paid to symptoms such as hypotension, renal function abnormalities, hyperkalemia, and angioedema. For patients with renal impairment or those with reduced blood volume, their condition should be corrected before administration, and appropriate measures should be taken if symptoms of hypotension arise. This drug can interact with other antihypertensives, particularly when used with RAAS agents, increasing the risk of renal function deterioration and hyperkalemia. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should avoid taking it or discontinue breastfeeding. It is not recommended for children as safety and efficacy have not been established. In the elderly, close monitoring is required to reduce the risk of stroke due to excessive blood pressure lowering. In case of overdose, symptoms such as hypotension, dizziness, acute renal failure may appear, requiring immediate treatment, and this drug is not removed by dialysis. This medication should be kept out of reach of children, and packaging should be opened just before use. Caution is advised when driving or operating machinery, as fainting or dizziness may occur. If abnormal symptoms occur during the course of treatment, prompt consultation with healthcare professionals is required.

Side effects

  • Upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
Show 79 more
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal bloating
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug eruption
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • palpitations
  • nausea
  • lack of efficacy
  • angioedema
  • shock
  • loss of consciousness
  • jaundice
  • anaphylaxis-like symptoms
  • interstitial pneumonia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at a temperature between 1°C and 30°C. Proper storage helps maintain the drug's efficacy and prevents deterioration.

Appearance and packaging

Appearance

White or nearly white, biconvex, round tablets

Package unit

10 tablets/blister X 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.